Link to EAHP Statements
- Section 1 – Introductory Statements and Governance: Statements - 1.1
- Section 2 – Selection, Procurement and Distribution: Statements - 2.2, 2.7
- Section 3 - Production and Compounding: Statements - 3.4, 3.5, 3.6
- Section 4 – Clinical Pharmacy Services : Statements - 4.1, 4.4, 4.5, 4.6, 4.7
- Section 5 - Patient Safety and Quality Assurance : Statements - 5.2, 5.4, 5.8, 5.9, 5.10, 5.11
- Section 6 - Education and Research: Statements - 6.2, 6.5
In modern patient centered healthcare systems, patient involvement is endorsed as it promotes patients’ compliance in medication therapy and ensures safer and more effective use of medicines. Hospital pharmacists, especially those involved in clinical pharmacy services for inpatients or outpatients’ services, are in physical contact with patients and carers, and must ensure that all relevant information is accurately shared by both the patient/and or carer and the responsible pharmacist, regarding treatments their patients receive.
Special groups of patients, such as pediatric or geriatric, immunosuppressed (hiv, transplantation, cancer), early access programs’ or clinical trials’ patients, usually need special advice by their healthcare supporting team. After some time, these patients/carers usually become their own “medication experts” and can explain in detail possible adverse reactions and problems. So, it is very significant for medication safety issues that especially these categories of patients are involved in reporting therapy problems in clear and definite way to the healthcare personnel.
Hospital pharmacists can create and implement the effective communication network, including other healthcare professionals (inside and outside their hospital, but close to the patients) and patients’ representatives, even representatives from the hospital management and local/central authorities. Such collaborative teams work together to face possible problems such as limited access to therapies due to shortages, or organize seminars to inform in detail patients and carers in pharmacovigilance matters and procedures and other medication safety issues.
After the session, participants should be able to:
- Understand all stages that patients’ involvement is critical regarding crucial information when getting medication history and performing medication review
- Ensure that patients of all categories and their carers are properly informed for their medicines in terms they can fully understand and participate in necessary reporting procedures
- Design and implement the necessary framework of procedures and communication paths that include immediate reporting of medication safety problems to the responsible healthcare personnel
Educational need addressed
All hospital pharmacists, especially those employed in clinical pharmacy services and outpatients’ pharmaceutical care.
patient involvement, collaborative teams, medication safety, patient groups, clinical trials